198 related articles for article (PubMed ID: 22744630)
1. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures.
Kaniuka-Jakubowska S; Biernat W; Lewczuk A; Świątkowska-Stodulska R; Sworczak K
Endokrynol Pol; 2012; 63(3):234-8. PubMed ID: 22744630
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.
Farmakis SG; Siegel MJ
Pediatr Radiol; 2015 Aug; 45(9):1423-6. PubMed ID: 25721582
[TBL] [Abstract][Full Text] [Related]
3. [Oncogenic osteomalacia and its symptoms: hypophosphatemia, bone pain and pathological fractures].
Kaniuka-Jakubowska S; Biernat W; Sworczak K
Postepy Hig Med Dosw (Online); 2012 Aug; 66():554-67. PubMed ID: 22922156
[TBL] [Abstract][Full Text] [Related]
4. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
5. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
6. The Right Leg that Troubled the Left Leg.
B S; V A
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic osteomalacia associated with phosphaturic mesenchymal tumour, mixed connective tissue type of the knee.
Szumera-Ciećkiewicz A; Ptaszyński K; Pawełas A; Rutkowski P
Pol J Pathol; 2009; 60(4):193-8. PubMed ID: 20200786
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
Garg B; Mehta N; Goyal A; Khadgawat R
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases].
Gronskaia SA; Belaya ZE; Rozhinskaya LY; Melnichenko GA; Dubovitskaya TA; Mamedova EO; Rodionova SS; Buklemishev YV; Pigarova EA; Degtyarev MV; Babaeva DM; Vladimirova VP; Tarbaeva NV; Serzhenko SS; Grigoriev AY; Dzeranova LK; Karpenko VY; Karasev AL; Fedotov RN; Uliyanova IN; Toroptsova NV; Lesnyak OM; Mokrysheva NG; Dedov II
Probl Endokrinol (Mosk); 2023 Nov; 69(5):25-38. PubMed ID: 37968949
[TBL] [Abstract][Full Text] [Related]
10. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia.
Reis-Filho JS; Paiva ME; Lopes JM
Brain Pathol; 2004 Jan; 14(1):111-2, 115. PubMed ID: 14997944
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
12. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
[TBL] [Abstract][Full Text] [Related]
13. [Oncogenic osteomalacia in a 49-year-old female patient].
Ludwig J; Mechtersheimer G; Haberkorn U; Nawroth P; Schilling T; Kasperk C
Dtsch Med Wochenschr; 2005 Feb; 130(5):206-9. PubMed ID: 15678388
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.
Yang IM; Park YK; Hyun YJ; Kim DY; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
Korean J Intern Med; 1997 Jan; 12(1):89-95. PubMed ID: 9159046
[TBL] [Abstract][Full Text] [Related]
15. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
Tsujimura T; Sakaguchi K; Aozasa K
Pathol Int; 1996 Mar; 46(3):238-41. PubMed ID: 10846577
[TBL] [Abstract][Full Text] [Related]
16. Phosphaturic mesenchymal tumor: two contrasting cases.
Koplas MC; Rubin BP; Sundaram M
Skeletal Radiol; 2014 Jun; 43(6):841-5. PubMed ID: 24402445
[No Abstract] [Full Text] [Related]
17. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
Seemann L; Padala SA; Mohammed A; Belayneh N
J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Induced Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Sole Presenting as a Crippling Illness in a Postmenopausal Woman.
Fang X; Zhang W; Yu Z; Liu H; Xiong Y; Luo Y; Song L; Li J; Duan H
J Foot Ankle Surg; 2020; 59(5):1113-1117. PubMed ID: 32622675
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
20. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
Vollmer S; Olsson K
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]